These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 39252705)

  • 1. Efficacy and Safety of Terlipressin Infusion in Hepatorenal Syndrome-Acute Kidney Injury (HRS-AKI): A Retrospective Observational Study.
    Gowda M; Dilipbhai DM; Jalihal U; Kumar MP; Gowda S B; Jain A; Ganjoo N
    Cureus; 2024 Aug; 16(8):e66581. PubMed ID: 39252705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review.
    Flamm SL; Wong F; Ahn J; Kamath PS
    Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. INFUSE: Rationale and design of a multi-center, open label, collaborative study to treat HRS-AKI with continuous terlipressin infusion.
    Weinberg E; Rahematpura S; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Ikahihifo-Bender J; Harte M; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K; Fricker Z; Reddy KR
    Contemp Clin Trials Commun; 2023 Dec; 36():101211. PubMed ID: 37953795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.
    Reddy KR; Weinberg EM; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Fricker Z; Ikahihifo-Bender J; Harte M; Garcia S; Campbell K; Olofson A; Razavi RF; James JM; Patel H; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K
    Liver Transpl; 2024 Oct; 30(10):1026-1038. PubMed ID: 38771635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study.
    Kulkarni AV; Ravikumar ST; Tevethia H; Premkumar M; Kumar K; Sharma M; Gupta R; Rao PN; Reddy DN
    Sci Rep; 2022 Apr; 12(1):5503. PubMed ID: 35365736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review.
    Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW
    Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome-Acute Kidney Injury.
    Agrawal J; Kumar A; Sharma P; Bansal N; Singla V; Sharma S; Arora A
    J Clin Exp Hepatol; 2024; 14(1):101266. PubMed ID: 38107184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis.
    Ma AT; Solé C; Juanola A; Escudé L; Napoleone L; Avitabile E; Pérez-Guasch M; Carol M; Pompili E; Gratacós-Ginés J; Soria A; Rubio AB; Cervera M; Moreta MJ; Morales-Ruiz M; Solà E; Poch E; Fabrellas N; Graupera I; Pose E; Ginès P
    J Hepatol; 2024 Sep; 81(3):441-450. PubMed ID: 38479614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous terlipressin infusion versus bolus in patients with acute-on-chronic liver failure-acute kidney injury - an open label RCT.
    Gupta T; Goel A; Ranga N; Goyal SK
    Clin Exp Hepatol; 2023 Dec; 9(4):351-358. PubMed ID: 38774204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoconstrictor Therapy for Acute Kidney Injury Hepatorenal Syndrome: A Meta-Analysis of Randomized Studies.
    Singal AK; Palmer G; Melick L; Abdallah M; Kwo P
    Gastro Hep Adv; 2023; 2(4):455-464. PubMed ID: 39132033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1.
    Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC;
    Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-HERO: hepatorenal syndrome-acute kidney injury (HRS-AKI) treatment with transjugular intrahepatic portosystemic shunt in patients with cirrhosis-a randomized controlled trial.
    Ripoll C; Platzer S; Franken P; Aschenbach R; Wienke A; Schuhmacher U; Teichgräber U; Stallmach A; Steighardt J; Zipprich A;
    Trials; 2023 Apr; 24(1):258. PubMed ID: 37020315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study.
    Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A
    Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Perioperative Terlipressin Therapy for Preventing Acute Kidney Injury in Living Donor Liver Transplant Recipients: A Systematic Review and Meta-Analysis.
    Kulkarni AV; Kumar K; Candia R; Arab JP; Tevethia HV; Premkumar M; Sharma M; Menon B; Rao GV; Reddy ND; Rao NP
    J Clin Exp Hepatol; 2022; 12(2):417-427. PubMed ID: 35535072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage liver disease: Management of hepatorenal syndrome.
    Mauro E; Garcia-Olveira L; Gadano A
    Liver Int; 2021 Jun; 41 Suppl 1():119-127. PubMed ID: 34155791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatorenal Syndrome With Acute Kidney Injury: Diagnosis and Medical Management.
    Erstad BL
    Ann Pharmacother; 2024 Feb; 58(2):156-164. PubMed ID: 37271967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study).
    Jindal A; Singh H; Kumar G; Arora V; Sharma MK; Maiwall R; Rajan V; Tewathia HV; Vasishtha C; Sarin SK
    Dig Dis Sci; 2024 Jun; 69(6):2204-2214. PubMed ID: 38637454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terlipressin for hepatorenal syndrome.
    Wong F
    Curr Opin Gastroenterol; 2024 May; 40(3):156-163. PubMed ID: 38353275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in acute kidney injury stage predicts survival in patients with type-1 hepatorenal syndrome.
    Wong F; Boyer TD; Sanyal AJ; Pappas SC; Escalante S; Jamil K
    Nephrol Dial Transplant; 2020 Sep; 35(9):1554-1561. PubMed ID: 30887050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel predictors of response to therapy with terlipressin and albumin in hepatorenal syndrome-acute kidney injury.
    Narayanan V; Devadas K; Sreesh S; Varghese J; Solanki R; Mohapatra SD; Pal R; Madhu D; Chakravorty A
    Ann Gastroenterol; 2024; 37(1):81-88. PubMed ID: 38223250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.